Pramlintide
A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
AstraZeneca · Phase 2 · Completed · Enrollment 400
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.